dehydroepiandrosterone has been researched along with 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)- in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
El-Nikhely, N; Eldemellawy, M; Elkewedi, M; Hassan, M; Saeed, H; Shalaby, M; Soudan, H | 1 |
1 other study(ies) available for dehydroepiandrosterone and 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-
Article | Year |
---|---|
Heat shock protein 90α inhibitor, PU-H71 in combination with DHEA promoting apoptosis in triple-negative breast cancer cell line MDA-MB-231.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzodioxoles; Caspases; CDC2 Protein Kinase; Cell Line, Tumor; Dehydroepiandrosterone; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; HSP90 Heat-Shock Proteins; Humans; Ki-67 Antigen; Models, Biological; NF-E2-Related Factor 2; Purines; Triple Negative Breast Neoplasms | 2020 |